Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dyne Therapeutics, Inc.

11.41
+0.11501.02%
Volume:4.52M
Turnover:52.04M
Market Cap:1.30B
PE:-3.15
High:12.01
Open:11.44
Low:11.18
Close:11.30
Loading ...

Stock Track | Dyne Therapeutics Soars 5.45% in Pre-Market on Positive Analyst Ratings and Strategic Progress

Stock Track
·
09 May

RBC Cuts Price Target on Dyne Therapeutics to $30 From $36, Keeps Outperform, Speculative Risk

MT Newswires Live
·
09 May

Dyne Therapeutics: Strategic Advancements and Strong Financials Support Buy Rating

TIPRANKS
·
09 May

Dyne Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Dyne Therapeutics Reports Q1 2025 R&D Expenses Surge to $106.4M, Cash Reserves at $677.5M

Reuters
·
08 May

Dyne Therapeutics Q1 Basic EPS USD -1.05

THOMSON REUTERS
·
08 May

Dyne Therapeutics Gets EU Orphan Drug Status for Duchenne Treatment

MT Newswires Live
·
24 Apr

BRIEF-Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation For DYNE-251 In Duchenne Muscular Dystrophy

Reuters
·
24 Apr

Dyne Therapeutics Receives European Medicines Agency (Ema) Orphan Drug Designation for Dyne-251 in Duchenne Muscular Dystrophy

THOMSON REUTERS
·
24 Apr

Dyne Therapeutics appoints Ranade as CBO, Batra as CSO

TIPRANKS
·
15 Apr

Press Release: Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments

Dow Jones
·
15 Apr

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
15 Apr

Insider Purchases Worth US$1.06m See Losses As Dyne Therapeutics Market Value Drops To US$770m

Simply Wall St.
·
10 Apr

Dyne Therapeutics Inc : RBC Cuts Target Price to $36 From $41

THOMSON REUTERS
·
03 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Dyne Therapeutics Is Maintained at Neutral by JP Morgan

Dow Jones
·
22 Mar

Sector Update: Health Care Stocks Steady Premarket Friday

MT Newswires Live
·
21 Mar

U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose

Reuters
·
21 Mar

Dyne Therapeutics Inc : JP Morgan Cuts Target Price to $17 From $18

THOMSON REUTERS
·
21 Mar

Dyne Therapeutics Names Erick Lucera as CFO

MT Newswires Live
·
21 Mar